Rose hips as complementary and alternative medicine: overview of the present status and prospects

Review

Abstract

Generally, the rose hips are discarded as horticultural wastes. Recently, they have been discovered to be storehouse of nutraceuticals and pharmaceuticals. Rich in polyphenols, essential fatty acids, vitamin A and C, mineral Ca and Fe, they have potential to be developed as functional foods. The extracts have demonstrated antioxidant, antiarthritic, antiinflammatory, analgesic, antidiabetic, cardioprotective, antimicrobial, immunomodulatory, gastroprotective and skin ameliorative effects. A slew of rose hip-based pharmaceutical supplements are already released to the market. Since very long, the indigenous traditional knowledge has accepted the medicinal value of rose hips. Now, modern clinical science is waking up to the rationale behind their incorporation in therapeutic regimens. This review has been compiled with a vision to promote the scarcely studied and barely exploited nutritional source as a nutraceutical aid and complementary and alternative medicine.

Keywords

Rose hips Functional food Antioxidant Antiinflammatory Antidiabetic Antimicrobial 

References

  1. 1.
    Guo D, Xu L, Cao X, Guo Y, Ye Y, Chan C-O, Mok DKW, Yu Z, Chen S (2011) Anti-inflammatory activities and mechanisms of action of the petroleum ether fraction of Rosa multiflora Thunb. hips. J Ethnophrmacol 138:717–722CrossRefGoogle Scholar
  2. 2.
    Chrubasik C, Roufogalis BD, Müller-Ladner U, Chrubasik S (2008) A systematic review on the Rosa canina effect and efficacy profiles. Phytother Res 22:725–733CrossRefGoogle Scholar
  3. 3.
    Salminen J-P, Karonen M, Lempa K, Liimatainen J, Sinkkonen J, Lukkarinen M, Pihlaja K (2005) Characterisation of proanthocyanidin aglycones and glycosides from rose hips by high-performance liquid chromatography–mass spectrometry, and their rapid quantification together with vitamin C. J Chromatogr A 1077:170–180CrossRefGoogle Scholar
  4. 4.
    Strålsjö L, Alklint C, Olsson ME, Sjöholm I (2003) Total folate content and retention in rosehips (Rosa ssp.) after drying. J Agric Food Chem 51:4291–4295CrossRefGoogle Scholar
  5. 5.
    Andersson SC, Rumpunen K, Johansson E, Olsson ME (2011) Carotenoid content and composition in rose hips (Rosa spp.) during ripening, determination of suitable maturity marker and implications for health promoting food products. Food Chem 128:689–696CrossRefGoogle Scholar
  6. 6.
    Yilmaz SO, Ercisli S (2011) Antibacterial and antioxidant activity of fruits of some rose species from Turkey. Romanian Biotechnol Lett 16 (4)Google Scholar
  7. 7.
    Evin D (2011) Investigation on the drying kinetics of sliced and whole rosehips at different moisture contents under microwave treatment. Sci Res Essays 6:2337–2347Google Scholar
  8. 8.
    Erenturk S, Gulaboglu MS, Gultekin S (2005) The effects of cutting and drying medium on the vitamin C content of rosehip during drying. J Food Eng 68:513–518CrossRefGoogle Scholar
  9. 9.
    Mabellini A, Ohaco E, Ochoa MR, Kesseler AG, Márquez CA, De Michelis A (2011) Chemical and physical characteristics of several wild rose species used as food or food ingredient. Int J Ind Chem 2:158–171Google Scholar
  10. 10.
    Szentmihályi K, Vinkler P, Lakatos B, Illés V, Then M (2002) Rose hip (Rosa canina L.) oil obtained from waste hip seeds by different extraction methods. Bioresour Technol 82:195–201CrossRefGoogle Scholar
  11. 11.
    Concha J, Soto C, Zuniaga ME (2004) Enzymatic pretreatment on rose-hip oil extraction: hydrolysis and pressing conditions. J Am Oil Chem Soc 81:549–552CrossRefGoogle Scholar
  12. 12.
    Tozzi R, Mulinacci N, Storlikken K, Pasquali I, Vincieri FF, Bettini R (2008) Supercritical extraction of carotenoids from Rosa canina L. hips and their formulation with β-cyclodextrin. AAPS PharmSci Tech 9:693–700CrossRefGoogle Scholar
  13. 13.
    Machmudah S, Kawahito Y, Sasaki M, Goto M (2008) Process optimization and extraction rate analysis of carotenoids extraction from rosehip fruit using supercritical CO2. J Supercrit Fluids 44:308–314CrossRefGoogle Scholar
  14. 14.
    Güne M (2010) Pomological and phenological characteristics of promising rose hip (Rosa) genotypes. Afr J Biotechnol 9:6301–6306Google Scholar
  15. 15.
    Gharabaghi PM, Tabatabei F, Fard SA, Sayyah-Melli M, Ouladesahebmadarek E, Del Azar A, Khoei SA, Gharabaghi MM, Ghojazadeh M, Mashrabi O (2011) Evaluation of the effect of preemptive administration of Rosa damascena extract on post-operative pain in elective cesarean sections. Afr J Pharm Pharmacol 5:1950–1955Google Scholar
  16. 16.
    Barros L, Carvalho AM, Ferreira ICFR (2011) Exotic fruits as a source of important phytochemicals: improving the traditional use of Rosa canina fruits in Portugal. Food Res Int 44:2233–2236CrossRefGoogle Scholar
  17. 17.
    Rosu CM, Manzu C, Olteanu Z, Oprica L, Oprea A, Ciornea E, Zamfirache MM (2011) Several fruit characteristics of Rosa sp. genotypes from the North-eastern region of Romania. Not Bot Horti Agrobo 39:203–208Google Scholar
  18. 18.
    Mocanu G-D, Rotaru G, Botez E, Gîtin L, Andronoiu D-G, Nistor O, Vlăsceanu G, Dune A (2009) Sensory evaluation and rheological behavior of probiotic dairy products with Rosa canina L. and Glycyrriza glabra L. extracts. Innov Romanian Food Biotechnol (4)Google Scholar
  19. 19.
    Bohm V, Frohlich K, Bitsch R (2003) Rosehip—a “new” source of lycopene? Mol Aspects Med 24:385–389CrossRefGoogle Scholar
  20. 20.
    Wenzig EM, Widowitz U, Kunert O, Chrubasik S, Bucar F, Knauder E, Bauer R (2008) Phytochemical composition and in vitro pharmacological activity of two rose hip (Rosa canina L.) preparations. Phytomedicine 15:826–835CrossRefGoogle Scholar
  21. 21.
    Gao X, Björk L, Trajkovski V, Uggla M (2000) Evaluation of antioxidant activities of rosehip ethanol extracts in different test systems Journal of the Science of Food and Agric 80:2021–2027Google Scholar
  22. 22.
    Yi O, Jovel EM, Towers GH, Wahbe TR, Cho D (2007) Antioxidant and antimicrobial activities of native Rosa sp. from British Columbia, Canada. Int J Food Sci Nutr 58:178–189CrossRefGoogle Scholar
  23. 23.
    Yoo KM, Lee CH, Lee H, Moon BK, Lee CY (2008) Relative antioxidant and cytoprotective activities of common herbs. Food Chem 106:929–936CrossRefGoogle Scholar
  24. 24.
    Rein E, Kharazmi A, Winther K (2004) A herbal remedy, Hyben Vital (stand. powder of a subspecies of Rosa canina fruits), reduces pain and improves general well-being in patients with osteoarthritis-a double-blind, placebo-controlled, randomised trial. Phytomedicine 11:383–391CrossRefGoogle Scholar
  25. 25.
    Winther K, Apel K, Thamsborg G (2005) A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial. Scand J Rheumatol 34:302–308CrossRefGoogle Scholar
  26. 26.
    Ameye LG, Chee WSS (2006) Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther 8:R127CrossRefGoogle Scholar
  27. 27.
    Chrubasik C, Duke RK, Chrubasik S (2006) The evidence for clinical efficacy of rose hip and seed: a systematic review. Phytother Res 20:1–3CrossRefGoogle Scholar
  28. 28.
    Rossnagel K, Roll S, Willich SN (2007) The clinical effectiveness of rosehip powder in patients with osteoarthritis: a systematic review. MMW Fortschr Med 149:51–56Google Scholar
  29. 29.
    Jager AK, Petersen KN, Thomasen G, Christensen SB (2008) Isolation of linoleic and alpha-linolenic acids as COX-1 and -2 inhibitors in rose hip. Phytother Res 22:982–984CrossRefGoogle Scholar
  30. 30.
    Christensen R, Bartels EM, Altman RD, Astrup A, Bliddal H (2008) Does the hip powder of Rosa canina (rosehip) reduce pain in osteoarthritis patients? A meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 16:965–972CrossRefGoogle Scholar
  31. 31.
    Cameron M, Gagnier JJ, Little CV, Parsons TJ, Blumle A, Chrubasik S (2009) Evidence of effectiveness of herbal medicinal products in the treatment of arthritis. Part I: Osteoarthritis. Phytother Res 23:1497–1515CrossRefGoogle Scholar
  32. 32.
    Willich SN, Rossnagel K, Roll S, Wagner A, Mune O, Erlendson J, Kharazmi A, Sörensen H, Winther K (2010) Rose hip herbal remedy in patients with rheumatoid arthritis: a randomised controlled trial. Phytomedicine 17:87–93CrossRefGoogle Scholar
  33. 33.
    De Silva V, El-Metwally A, Ernst E, Lewith G, Macfarlane GJ (2011) Evidence for the efficacy of complementary and alternative medicines in the management of osteoarthritis: a systematic review. Rheumatology (Oxford) 50:911–920CrossRefGoogle Scholar
  34. 34.
    Deliorman OD, Harteviollu A, Küpeli E, Yesilada E (2007) In vivo anti-inflammatory and antinociceptive activity of the crude extract and fractions from Rosa canina fruits. J Ethnopharmacol 112:394–400CrossRefGoogle Scholar
  35. 35.
    Lattanzio F, Greco E, Carretta D, Cervellati R, Govoni P, Speroni E (2011) In vivo anti-inflammatory effect of Rosa canina L. extract. Phytother Res 137:880–885Google Scholar
  36. 36.
    Larsen E, Kharazmi A, Christensen LP, Christensen SB (2003) An antiinflammatory galactolipid from rose hip (Rosa canina) that inhibits chemotaxis of human peripheral blood neutrophils in vitro. J Nat Prod 66:994–995CrossRefGoogle Scholar
  37. 37.
    Schwager J, Hoeller U, Wolfram S, Richard N (2011) Rose hip and its constituent galactolipids confer cartilage protection by modulating cytokine, and chemokine expression. BMC Complement Alt Med 11:105Google Scholar
  38. 38.
    Orhan N, Aslan M, Hosbas S, Deliorman OD (2009) Antidiabetic effect and antioxidant potential of Rosa canina fruits. Pharmacog Mag 5:309–315CrossRefGoogle Scholar
  39. 39.
    Andersson U, Henriksson E, Ström K, Alenfall J, Göransson O, Holm C (2011) Rose hip exerts anti-diabetic effects via a mechanism involving downregulation of the hepatic lipogenic program. Am J Physiol Endocrinol Metab 300:111–121CrossRefGoogle Scholar
  40. 40.
    Andersson U, Berger K, Högberg A, Landin-Olsson M, Holm C (2011) Effects of rose hip intake on risk markers of type 2 diabetes and cardiovascular disease: a randomized, double-blind, cross-over investigation in obese persons. Eur J Clinical Nutrition. doi:10.1038/ejcn.2011.203 Google Scholar
  41. 41.
    Saaby L, Nielsen CH (2011) Triterpene acids from rose hip powder inhibit self-antigen- and LPS-induced cytokine production and CD4 (+) T-cell proliferation in human mononuclear cell cultures. Phytother Res. doi:10.1002/ptr.3713 Google Scholar
  42. 42.
    Saaby L, Jager AK, Moesby L, Hansen EW, Christensen SB (2011) Isolation of immunomodulatory triterpene acids from a standardized rose hip powder (Rosa canina L.). Phytother Res 25:195–201Google Scholar
  43. 43.
    Hakansson A, Stene C, mihaescu A, Molin G, Ahrne S, Thorlacius H, Jeppsson B (2006) Rose hip and Lactobacillus plantarum DSM 9843 reduce ischemia/reperfusion injury in the mouse colon. Digest Dis Sci 51:2094–2101Google Scholar
  44. 44.
    Fujii T, Saito M (2009) Inhibitory effect of quercetin isolated from rose hip (Rosa canina L.) against melanogenesis by mouse melanoma cells. Biosci Biotechnol Biochem 73:1989–1993CrossRefGoogle Scholar
  45. 45.
    Fujii T, Ikeda K, Saito M (2011) Inhibitory effect of rose hip (Rosa canina L.) on melanogenesis in mouse melanoma cells and on pigmentation in brown guinea pigs. Biosci Biotechnol Biochem 75:489–495CrossRefGoogle Scholar
  46. 46.
    Werlemark G (2009) Dog rose: wild plant, bright future. Chron Hortic 49:8–13Google Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  1. 1.Affiliated to Better Process Control School Department of Food Science and TechnologyUniversity of CaliforniaDavisUSA

Personalised recommendations